SAMe-TT2R2 Score Calculator
Warfarin Control Assessment
Select the option that best describes the patient. The score updates automatically.
If warfarin is selected, use appropriate INR monitoring, education, and follow-up. Review the patient's clinical circumstances and anticoagulation indication.
The score estimates the likelihood of warfarin control; it does not calculate an individual TTR, stroke risk, or bleeding risk. For eligible patients with atrial fibrillation, DOACs are generally preferred over VKAs. DOACs are not appropriate substitutes in patients with mechanical heart valves or moderate-to-severe mitral stenosis.
About the SAMe-TT₂R₂ Score
The SAMe-TT₂R₂ score was developed to help identify patients with atrial fibrillation who may be less likely to achieve good anticoagulation control with a vitamin K antagonist such as warfarin. It is a decision-support aid, not a substitute for measured INR control or clinical assessment.
Variables and points
| Component | Criterion | Points |
|---|---|---|
| Sex | Female | +1 |
| Age | Under 60 years | +1 |
| Medical history | More than two comorbidities | +1 |
| Treatment | Interacting drug, e.g. amiodarone | +1 |
| Tobacco | Use within the past two years | +2 |
| Race | Non-Caucasian | +2 |
Interpretation
| Score | Interpretation | Practical implication |
|---|---|---|
| 0–2 | More favorable likelihood of good warfarin control | Warfarin may be considered when otherwise appropriate; monitor INR and assess actual TTR. |
| >2 | Higher likelihood of suboptimal warfarin control | If a VKA is used, consider closer review, education, and INR monitoring; reassess anticoagulant choice when eligible. |
Important clinical context
- Actual anticoagulation quality should be assessed using INR history and time in therapeutic range, rather than inferred from this score alone.
- For atrial fibrillation, the usual VKA target INR is 2.0–3.0; a TTR above 70% is generally desirable.
- DOACs are generally preferred over VKAs in eligible patients, but not for mechanical heart valves or moderate-to-severe mitral stenosis.
- The original score includes race as a predictor. Its calibration and performance may vary between populations, so local applicability should be considered.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.